Decreases in cerebral saturation in patients with septic shock are associated with increased risk of death: a prospective observational single center study

Table 1 Baseline data for the patients with septic shock

Patient	PMHx	Source of sepsis	Organism	Outcome	CAM	AKI	SOFA	APACHE	Mechanical ventilation
1	EtOH abuse	Lung	None recovered	Dead	CAM+	Yes	23	24	Yes
2	HIV, IHD	Lung	Streptococcus pneumoniae	Alive	CAM−	Yes	15	28	Yes
3	CHF	Lung	None recovered	Alive	CAM+	Yes	17	24	Yes
4	None	Heart/lung	Staphylococcus aureus	Alive	CAM+	Yes	18	19	Yes
5	IVDU, Hep C	Bacteremia	GNB	Dead	CAM+	Yes	22	26	Yes
6	None	Abdomen	None recovered	Alive	CAM+	No	10	15	Yes
7	Pancreatitis, EtOH, DM2	Abdomen	None recovered	Alive	CAM−	No	8	16	Yes
8	Smoker, Asthma	Lung	None recovered	Alive	CAM−	No	15	18	Yes
9	DM2, HTN, IHD, UGIB	Lung	Pseudomonas sp.	Alive	CAM−	Yes	15	30	Yes
10	None	Lung	None recovered	Alive	CAM−	No	6	9	No
11	DM2, CMP, COPD	Ischemic foot	S. aureus	Dead	CAM+	Yes	20	26	Yes
12	CHF, CRI, RA	Necrotizing fasciitis	Pseudomonas	Dead	CAM−	Yes	19	23	Yes
13	DM2, PVD	Leg	β-hemolytic strep	Alive	CAM−	Yes	13	21	Yes
14	Developmental delay	Abdomen	Non-hemolytic Streptococcus	Alive	CAM−	Yes	12	27	Yes
15	Autoimmune hepatitis, portal HTN, ESRD	Ankle	None recovered	Alive	CAM+	No	16	23	No

PMHx past medical history, CAM-ICU confusion assessment method, AKI acute kidney injury, EtOh ethanol, HIV human immunodeficiency virus, IHD ischemic heart disease, CHF congestive heart failure, IVDU intravenous drug use, HEP C hepatitis C virus, DM2 type 2 diabetes, HTN hypertension, UGIB upper gastrointestinal bleed, CMP cardiomyopathy, COPD chronic obstructive pulmonary disease, CRI chronic renal insufficiency, RA rheumatoid arthritis, PVD peripheral vascular disease, ESRD end-stage renal disease